Table 1 Patient demographics and treatment characteristics: ERP vs. control
Control (N = 464) | ERP (N = 590) | p value | |
|---|---|---|---|
Age (years, median [IQR]) | 60 [51–71] | 60 [48–68] | 0.175 |
Sex | 0.316 | ||
Male | 48.9% (227) | 52.0% (307) | |
Female | 51.1% (237) | 48.0% (283) | |
Race | 0.749 | ||
White | 72.6% (337) | 74.7% (441) | |
Black | 23.5% (109) | 21.7% (128) | |
Others | 3.9% (18) | 3.6% (21) | |
ASA classification | < 0.001 | ||
1 | 1.7% (8) | 3.9% (23) | |
2 | 58.4% (271) | 34.4% (203) | |
≥ 3 | 39.9% (185) | 61.7% (364) | |
Indication | 0.045 | ||
Benign | 25.8% (120) | 19.3% (114) | |
IBD | 11.3% (52) | 12.9% (76) | |
Neoplastic | 62.9% (292) | 67.8% (400) | |
Extent of surgery | < 0.001 | ||
Colectomy | 88.1% (409) | 52.4% (309) | |
Proctectomy | 11.9% (55) | 47.6% (281) | |
Surgical approach | < 0.001 | ||
Laparoscopic | 48.7% (226) | 59.9% (353) | |
Open | 51.3% (238) | 40.1% (237) | |
Intra-op total fluid (mL, median [IQR]) | 3760 [2460–5351] | 3468 [2688–4536] | 0.233 |
Intra-op colloid (mL, median [IQR]) | 500 [0–1000] | 1000 [750–1500] | < 0.001 |
Pre-op hemoglobin (mg/dL, median [IQR]) | 13.4 [11.8–14.5] | 13.3 [11.8–14.5] | 0.401 |